Chou Associates Management’s Teva Pharmaceuticals TEVA Stock Holding History

Chou Associates Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-15,000	Closed	-$103K	–	21
2019 Q3	$103K	Hold	15,000	–	–	0.06%	22
2019 Q2	$138K	Hold	15,000	–	–	0.06%	24
2019 Q1	$234K	Hold	15,000	–	–	0.1%	25
2018 Q4	$231K	Hold	15,000	–	–	0.1%	26
2018 Q3	$323K	Hold	15,000	–	–	0.11%	25
2018 Q2	$365K	Hold	15,000	–	–	0.14%	25
2018 Q1	$256K	Hold	15,000	–	–	0.11%	23
2017 Q4	$284K	Sell	15,000 -490,000	-97%	-$7.37M	0.12%	24
2017 Q3	$8.89M	Hold	505,000	–	–	3.11%	10
2017 Q2	$16.8M	Buy	505,000 +290,000	+135%	+$8.98M	5.2%	8
2017 Q1	$6.9M	Buy	+215,000	New	+$7.34M	2.29%	14

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Chou Associates Management's TEVA Position: Q4 2019 in Review

Chou Associates Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 15,000 shares — an estimated $103K sold.

Chou Associates Management first reported a position in TEVA in Q1 2017 and held it in 11 quarters. The position peaked at $16.8M in Q2 2017. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Chou Associates Management reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Chou Associates Management sold 15,000 Teva Pharmaceuticals shares in Q4 2019, an estimated $103K.
Chou Associates Management first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 11 quarters.
Chou Associates Management's Teva Pharmaceuticals position peaked at $16.8M in Q2 2017.
437 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on Chou Associates Management's 13F filing for Q4 2019, filed 4 Mar 2020.